MBX Biosciences Shares Are Trading Higher on Possible Continued Strength After the Company Announced Results From Its Phase 1 Single Ascending Dose and Multiple Ascending Dose Trial of MBX 1416 Yesterday.
MBX Biosciences Shares Are Trading Higher on Possible Continued Strength After the Company Announced Results From Its Phase 1 Single Ascending Dose and Multiple Ascending Dose Trial of MBX 1416 Yesterday.
MBX Biosciences的股票在公司昨天宣布MBX 1416的第一阶段单次递增剂量和多次递增剂量试验结果后，可能因持续强势而交易上涨。
MBX Biosciences Shares Are Trading Higher on Possible Continued Strength After the Company Announced Results From Its Phase 1 Single Ascending Dose and Multiple Ascending Dose Trial of MBX 1416 Yesterday.
MBX Biosciences公司昨天公布了MBX 1416的1阶段单一上升剂量和多次递增剂量试验的结果，其股价因可能持续走强而走高。
热门讨论
中概股财报季火热：惊喜盈利能否延续涨势？
1. 哪些行业可能成为本轮中概股财报季的市场焦点？ 2. 在政府强调科技创新和可持续发展的背景下，你认为哪些行业具有最大的增长潜力？
Moomoo News Global
03/04 23:26
中国两会：会议前后股票价格走势的主要要点